SPDR S&P Biotech ETF To Go Ex-Dividend On September 23rd, 2024 With 0.01523 USD Dividend Per Share
September 20th (Eastern Time) - $SPDR S&P Biotech ETF(XBI.US)$ is trading ex-dividend on September 23rd, 2024.Shareholders of record on September 23rd, 2024 will receive 0.01523 USD dividend per
Bristol-Myers Acquired Drug KarXT Poised For FDA Approval As First New Type Of Schizophrenia Treatment In 70 Years
Spotlight on AbbVie: Analyzing the Surge in Options Activity
Gilead Sciences Unusual Options Activity For September 20
Viking, Structure, Terns Benefitting From Disappointing Novo Nordisk Weight Loss Data
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
Jim Cramer: Viking Therapeutics Has 'Many Ships Coming In'
SPDR S&P Biotech ETF Options Spot-On: On September 19th, 109.02K Contracts Were Traded, With 1 Million Open Interest
On September 19th ET, $SPDR S&P Biotech ETF(XBI.US)$ had active options trading, with a total trading volume of 109.02K options for the day, of which put options accounted for 19.38% of the total
Behind the Scenes of Amgen's Latest Options Trends
Wells Fargo's 'Value Equity List' – Stocks With Potential That Trade at a Discount
Competitor Analysis: Evaluating AbbVie And Competitors In Biotechnology Industry
Halozyme Cut to Neutral at J.P. Morgan on Valuation
Unmissable investment strategy! The Federal Reserve officially enters a new era of interest rate cuts, these 6 industries have the most profitable potential.
Prepare yourself for the interest rate cut cycle.
Incyte, Syndax Report Publication Of Data From Pivotal AGAVE-201 Trial Of Niktimvo; Trial Met The Primary Endpoint Across All Cohorts
SPDR S&P Biotech ETF Options Spot-On: On September 18th, 131.66K Contracts Were Traded, With 933.6K Open Interest
On September 18th ET, $SPDR S&P Biotech ETF(XBI.US)$ had active options trading, with a total trading volume of 131.66K options for the day, of which put options accounted for 31.04% of the total
BeiGene Initiated at Outperform at JMP Securities on Strength of Brukinsa
Incyte Downgraded - Analyst Notes Intense Competition, Particularly In Larger Markets
10 Health Care Stocks With Whale Alerts In Today's Session
28 Top Rated U.S. Growth Stocks Month-to-date in Anticipation of Fed Cuts
Incyte Downgraded at Truist on Jakafi Patent Cliff